No-Moat Lundbeck's Strategic Brands Drive Growth but Face Generic Pressure Amid Patent Losses
However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...
openaccessgovernment1d
New NHS treatment offers hope for children with Lennox–Gastaut syndrome
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...
NHS England3d
NHS rolls out life-changing treatment offering ‘new hope’ for hundreds of children with severe epilepsy
Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures, providing new hope for them and their ...
Harmony Biosciences CEO says pipeline could push company over $3B in sales
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Forbes29d
Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug
Importantly, the results from this trial inform the doses to be evaluated in upcoming Phase 2 clinical trials of AJA001 in children, adolescents, and adults ... 2020 due to Dravet syndrome ...
Epilepsy Action26d
Epilepsy and cannabis-based medicines
These will investigate the safety and effectiveness of cannabidiol (CBD) and tetrahydrocannabinol (THC) in adults and children with treatment ... remain for those who don’t have a diagnosis of Dravet ...
National Health Executive2d
Groundbreaking new child epilepsy treatment
Starting today, the National Institute for Health and Care Excellence (NICE) has recommended the funding of fenfluramine for NHS patients in England. This new drug is specifically approved for ...